×

US Democrats ask Gilead about pricing

12:30 PM ET Fri, 21 March 2014

CNBC's Sheila Dharmarajan reports on the decline in the Nasdaq because of the hit to the biotechs. Gilead received a letter from senior Democrats requesting a briefing on the pricing for its hepatitis C drug Sovaldi.